Assessing the COVID-19 vaccine hesitancy in the Chinese adults using a generalized vaccine hesitancy survey instrument.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
02 11 2021
Historique:
entrez: 12 1 2022
pubmed: 13 1 2022
medline: 15 1 2022
Statut: ppublish

Résumé

The objectives of this study were to determine coronavirus disease 2019 (COVID-19) vaccination hesitancy and influencing factors in China, while broadening the applicability of the Vaccine Hesitancy Scale (VHS). A cross-sectional survey was conducted in China from 4th to 26th February 2021. Convenience sampling method was adopted to recruit participants. A total of 2,361 residents filled out the questionnaire. Confirmatory factor analysis was used on the validation set to confirm the latent structure that resulted from the exploratory factor analysis, which was conducted on the construction set. Multiple linear regression model analyses were used to identify significant associations between the identified the revised version of VHS subscales and hypothesized explanatory variables. Two subscales were identified within the VHS through data analysis, including "lack of confidence in the need for vaccines" and "aversion to the risk of side effects." The results indicated that the hesitancy of the participants in our sample was both driven the two mainly aspects. In addition, more than 40% of the participants expressed hesitation in half of the items in VHS. This study characterized COVID-19 vaccine hesitancy in China, and identified disparities in vaccine hesitancy by socio-demographic groups and knowledge about the vaccine. Knowledge of the vaccine was statistically linked to respondents' answers to the clustered 'lack of confidence' and 'risks perception' items. Our results characterize Chinese citizens' COVID-19 vaccine concerns and will inform targeted health communications.

Identifiants

pubmed: 35016491
doi: 10.1080/21645515.2021.1953343
pmc: PMC8828104
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4005-4012

Références

J Gen Psychol. 2015;142(2):71-89
pubmed: 25832738
Vaccine. 2012 May 28;30(25):3771-7
pubmed: 22445808
Vaccines (Basel). 2021 Mar 21;9(3):
pubmed: 33801136
Vaccines (Basel). 2019 Dec 20;8(1):
pubmed: 31861816
Int J Nurs Stud. 2021 Feb;114:103854
pubmed: 33326864
Papillomavirus Res. 2016 Dec;2:167-172
pubmed: 29074176
Vaccine. 2018 Aug 23;36(35):5273-5281
pubmed: 30061026
Hum Vaccin Immunother. 2021 Jul 3;17(7):2289-2292
pubmed: 33577397
Eur J Public Health. 2014 Apr;24(2):310-4
pubmed: 23813706
Ann Behav Med. 2017 Oct;51(5):652-660
pubmed: 28255934
Sex Transm Dis. 2010 Apr;37(4):234-9
pubmed: 19940807
Vaccine. 2014 Oct 29;32(47):6259-65
pubmed: 25258098
Vaccines (Basel). 2021 Feb 05;9(2):
pubmed: 33562894
Vaccine. 2014 Nov 20;32(49):6649-54
pubmed: 25280436
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Clin Pediatr (Phila). 2017 Jul;56(8):784-788
pubmed: 28589763
Vaccine. 2021 May 18;39(21):2833-2842
pubmed: 33896661
Vaccine. 2020 Nov 3;38(47):7464-7471
pubmed: 33041097
J Med Virol. 2020 Jul;92(7):755-769
pubmed: 32237160
Nat Rev Drug Discov. 2020 May;19(5):305-306
pubmed: 32273591
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961
pubmed: 33332359
Vaccine. 2011 Feb 11;29(8):1700-9
pubmed: 21185850
Vaccine. 2018 Jan 29;36(5):660-667
pubmed: 29289384
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Aug 10;39(8):1045-1050
pubmed: 30180426
Hum Vaccin. 2011 Apr;7(4):419-25
pubmed: 21389777
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384

Auteurs

Xin Shen (X)

Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Hao Dong (H)

Department of General Practice, Shouyilu Street Community Health Service Center, Wuhan, Hubei, China.

Jing Feng (J)

Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Heng Jiang (H)

Centre for Alcohol Policy Research, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.
Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.

Rowan Dowling (R)

Centre for Alcohol Policy Research, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.

Zuxun Lu (Z)

Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Chuanzhu Lv (C)

Department of Emergency, Hainan Clinical Research Center for Acute and Critical Diseases, the Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Emergency and Trauma College, Hainan Medical University, Haikou, Hainan, China.
Research Unit of Island Emergency Medicine, Chinese Academy of Medical Sciences (No. 2019RU013), Hainan Medical University, Haikou, Hainan, China.
Key Laboratory of Emergency and Trauma of Ministry of Education, Hainan Medical University, Haikou, Hainan, China.

Yong Gan (Y)

Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH